Clinical Trial Search Results
Treatment of Bone Marrow Failure, Post Allogeneic Bone Marrow Transplant,w ith CD34+ Cell-Enriched Hematopoietic Stem Cell Infusion (Miltenyi Biotec's CliniMACS CD34 Reagent System) A HDE Treatment Protocol
[Shell Only] - HUD/CUD.
Use of GID SVF-2 Device to Produce Autologous Adipose-Derived Stromal Vascular Fraction for Treatment of Osteoarthritis of the Knee: A Pivotal Medical Device Randomized Concurrent Controlled Study
A research study that intends to determine if an injection of stromal vascular fraction (SVF) cells derived from your own fat (adipose) will relieve pain and increase function in one of your osteoarthritic knees. The GID Group ...
Using Ultrasound to Estimate Endotracheal Size at Sub-Cricoid Level in Extremely Preterm Infants
The size of the endotracheal tube (ETT) is based on a baby's weight, not on the size of the trachea. This practice increases the risk of selecting an ETT that is inappropriately small and leads to sub-optimal breathing sup ...
Validating Cell-based assays for Antibody-mediated rejection after renal transplantation
The purpose of this study is to evaluate whether new blood tests can detect rejection due to antibodies after kidney transplantation. Rejection occurs in some patients who receive a kidney transplant. In some cases, immune cell ...
Validation of the Pediatric Critical-care Pain Observation Tool (P-COPT) in PICU and Pediatric CVICU
The specific aim of the proposed study is to further validate the P-CPOT in PICU and Pediatric CVICU ventilated patients who are 3 to 18 years.
VTEM PLASMA MARKERS - Plasma Biomarkers for Veno-ThromboEmbolic (VTE) Disease: Promise of Metabolomics (VTEM)
We invite you to take part in a research study because you have been diagnosed of having a blood clot in your body either in the legs called DVT deep vein thrombosis or possibly in your lungs called pulmonary embolism or PE. Y ...
You are being asked to take part in this research study because you have Systemic Juvenile Idiopathic Arthritis (sJIA) which may cause joint swelling and pain, fever, or other symptoms affecting the whole body (such as rash, swelling of your lymph nodes, a large liver or spleen, or inflammation of the lining around your lungs or heart). The purpose of this research study is to compare the effectiveness of the study drug, tofacitinib, to placebo for treatment of signs and symptoms of sJIA.
You are being asked to take part in this research study because you have Systemic Juvenile Idiopathic Arthritis (sJIA) which may cause joint swelling and pain, fever, or other symptoms affecting the whole body (such as rash, sw ...